Chapter 1. Cancer Diagnostics Market– Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Cancer Diagnostics Market– Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
            2.3.1    Impact during 2023 – 2030
            2.3.2    Impact on Supply – Demand
Chapter 3. Cancer Diagnostics Market– Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Cancer Diagnostics Market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
            4.4.1     Bargaining Power of Suppliers
            4.4.2     Bargaining Powers of Customers
            4.4.3    Threat of New Entrants
            4.4.4    .Rivalry among Existing Players
            4.4.5    Threat of Substitutes
Chapter 5. Cancer Diagnostics Market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Cancer Diagnostics Market- Technology 
6.1    Next-Generation Sequencing
6.2    qPCR & Multiplexing
6.3    Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
6.4    Protein Microarrays
6.5    DNA Microarrays
Chapter 7. Cancer Diagnostics Market- Application 
7.1    Biomarker Development
7.2    CTC Analysis
7.3    Proteomic Analysis
7.4    Epigenetic Analysis
7.5    Genetic Analysis
Chapter 8. Cancer Diagnostics Market - Cancer Type 
8.1    Lung Cancer
8.2    Breast Cancer
8.3    Colorectal Cancer
8.4    Cervical Cancer
8.5    Others
Chapter 9. Cancer Diagnostics Market- Function 
9.1    Therapeutic Monitoring
9.2    Companion Diagnostics
9.3    Prognostics
9.4    Cancer Screening
9.5    Risk Analysis
Chapter 10. Cancer Diagnostics Market– By Region
10.1    North America
10.2    Europe
10.3    Asia-Pacific
10.4    Latin America
10.5    The Middle East
10.6    Africa
Chapter 11. Cancer Diagnostics Market– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
11.1    Company 1
11.2    Company 2
11.3    Company 3
11.4    Company 4
11.5    Company 5
11.6    Company 6
11.7    Company 7
11.8    Company 8
11.9    Company 9
11.10    Company 10
 

Download Sample